Accumulation of phosphorylated α-synuclein in aging human brain

Journal of Neuropathology and Experimental Neurology

Volumn 62, Issue 6, 2003, Pages 644-654

  Yuko, Saito ^a   Akiko, Kawashima ^b   Ruberu, Nyoka N ^a,c   Hideo, Fujiwara ^b   Shunichi, Koyama ^a,d   Motoji, Sawabe ^e   Tomio, Arai ^e   Hiroshi, Nagura ^e   Hiroshi, Yamanouchi ^e   Masato, Hasegawa ^f   Takeshi, Iwatsubo ^b   Murayama, Shigeo ^a  

^a TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d TOKYO MEDICAL UNIVERSITY   (Japan)

^e Tokyo Metropolitan Institute of Gerontology   (Japan)

^f TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Axon; Dementia with Lewy bodies; Immunohistochemistry; Parkinson disease; Synapse; Synucleinopathy

Indexed keywords

ALPHA SYNUCLEIN; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY;

ADULT; AGED; AGING; ARTICLE; BRAIN CORTEX; CELL DEATH; CELL STRUCTURE; CONTROLLED STUDY; CYTOPLASM; DEMENTIA; DENDRITE; DISEASE ASSOCIATION; FEMALE; FRONTAL LOBE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LEWY BODY; MAJOR CLINICAL STUDY; MALE; NERVE CELL; NERVE FIBER; NERVE FIBER TRANSPORT; NEUROPIL; OCCIPITAL LOBE; PARIETAL LOBE; PERIKARYON; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SYNAPTIC TRANSMISSION; TEMPORAL LOBE; WHITE MATTER;

EID: 0037604508     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/62.6.644     Document Type: Article

References (27)

1. Kuzuhara S, Mori H, Izumiyama N, Yoshimura M, Ihara Y. Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study. Acta Neuropathol (Berl) 1988;75:345-53
2. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. α-Synuclein in Lewy bodies. Nature 1997;388:839-40
3. Baba M, Nakajo S, Tu PH, et al. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 1998;152:879-84
4. Iwanaga K, Wakabayashi K, Yoshimoto M, et al. Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases. Neurology 1999;52:1269-71
5. Jackson M, Lennox G, Balsitis M, Lowe J. Lewy body dysphagia. J Neurol Neurosurg Psychiatry 1995;58:756-58
6. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology 1996;47:1113-24
7. Lennox GG, Lowe J. Dementia with Lewy bodies. In: Markesbery WR, ed. Neuropathology of dementing disorders. London: Arnold, 1998:181-92
8. Esiri MM, McShane RH. Parkinson's disease and dementia. In: Esiri MM, Morris JH, eds. The neuropathology of dementia. Cambridge: Cambridge University Press, 1997:174-93
9. Del Tredici K, Rub U, De Vos RA, Bohl JR, Braak H. Where does Parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 2002;61:413-26
10. Lippa CF, Fujiwara H, Mann DM, et al. Lewy bodies contain altered α-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol 1998;153:1365-70
11. Arai Y, Yamazaki M, Mori O, Muramatsu H, Asano G, Katayama Y. α-Synuclein-positive structures in cases with sporadic Alzheimer's disease: Morphology and its relationship to tau aggregation. Brain Res 2001;888:287-96
12. Jakes R, Spillantini MG, Goedert M. Identification of two distinct synucleins from human brain. FEBS Lett 1994;345:27-32
13. Fujiwara H, Hasegawa M, Dohmae N, et al. α-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 2002;4:160-64
14. Saito Y, Nakahara K, Yamanouchi H, Murayama S. Severe involvement of ambient gyrus in dementia with grains. J Neuropath Exp Neurol 2002;61:789-96
15. McKeith IG, Perry EK, Perry RH. Report of the second dementia with Lewy body international workshop: Diagnosis and treatment. Consortium on Dementia with Lewy Bodies. Neurology 1999;53:902-5
16. Hasegawa M, Fujiwara H, Nonaka T, et al. Phosphorylated α-synuclein is ubiquitinated in α-synucleinopathy lesions. J Biol Chem 2002;277:49071-76
17. Kato T, Hirano A, Weinberg MN, Jacobs AK. Spinal cord lesions in progressive supranuclear palsy: Some new observations. Acta Neuropathol (Berl) 1986;71:11-14
18. Braak H, Braak E. Argyrophilic grains: Characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes. Neurosci Lett 1987;76:124-27
19. Ishii K, Yamaji S, Kitagaki H, Imamura T. Hirono N, Mori E. Regional cerebral blood flow difference between dementia with Lewy bodies and AD. Neurology 1999;53:413-16
20. Imamura T, Ishii K, Sasaki M, et al. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease: A comparative study using positron emission tomography. Neurosci Lett 1997;235:49-52
21. Forman MS, Schmidt ML. Kasturi S, Perl DP, Lee VM, Trojanowski JQ. Tau and α-synuclein pathology in amygdala of Parkinsonism-dementia complex patients of Guam. Am J Pathol 2002;160:1725-31
22. Saito Y, Kawai M, Inoue K, et al. Widespread expression of α-synuclein and tau immunoreactivity in Hallervorden-Spatz syndrome with protracted clinical course. J Neurol Sci 2000;177:48-59
23. Duda JE, Giasson BI, Mabon ME, Lee VMY, Trojanowski JQ. Novel antibodies to synuclein show abundant striatal pathology in Lewy body disease. Ann Neurol 2002;52:205-10
24. Piggott MA, Marshall EF, Thomas N, et al. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: Rostrocaudal distribution. Brain 1999;123:1449-68
25. Perry EK, Haroutunian V, Davis KL, et al. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. Neuroreport 1994;5:747-49
26. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-72
27. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991;82:339-59